Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Recruiting 3Completed 3Active not recruiting 2Terminated 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 5Gastrointestinal 5Genitourinary 3Other solid neoplasm 2Head & Neck 2Gynecologic 2Sarcoma 1Dermatologic 1CNS 1Breast 1

Conditions

Solid Tumors 1Solid Tumor 1

Interventions

pembrolizumab 27Nivolumab 11Pemetrexed 10Cyclophosphamide 10Carboplatin 10atezolizumab 9Specimen Handling 8Cisplatin 8Ipilimumab 6Biopsy 6Injections 5tislelizumab 4spartalizumab 4fludarabine 4Vincristine 4Radiotherapy 4Proton Therapy 4Platinum 4Paclitaxel 4Drug Therapy 4Docetaxel 4Bevacizumab 41,2-diaminocyclohexaneplatinum II citrate 4durvalumab 3Trastuzumab 3Etoposide 3Cetuximab 3zimberelimab 2trametinib 2tocilizumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × zimberelimab × Other solid neoplasm × Clear all
NCT06082960 2026-04-16

Study of GS-9911 With or Without Antibody Treatment for Adults With Solid Tumors

Gilead Sciences

Phase 1 Active not recruiting
45 enrolled
Other solid neoplasm

Solid Tumors

NCT05840224 2026-01-28

Study of GS-4528 in Adults With Solid Tumors

Gilead Sciences

Phase 1 Active not recruiting
182 enrolled
Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡